Both total body tamoxifen-inducible Cagg-Cre and kidney epithelium-specific KSP-Cre models of Tsc2 inactivation exhibit significant cystic kidney disease burden, decreased body weight and decreased survival. Here, TSC2 is linked to cystic kidney disease.